MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2
article
OA: gold
CC0
⤵ 14 in-corpus citations
AI-generated summary
Metastasis-associated protein 1 (MTA1) promotes epithelial-mesenchymal transition in endometriosis by interacting with ZEB2, and resveratrol suppresses these effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a benign disease that shares some malignant features. Epithelial-mesenchymal transition (EMT) is involved in the pathogenesis of endometriosis. Metastasis-associated protein 1 (MTA1) plays an important role in various cancers by promoting EMT, yet there are no studies on its function in endometriosis. In the present study, we found that MTA1 was highly expressed in the ectopic endometrium of endometriosis patients and that the expression of MTA1 was related to the revised American Fertility Society stage. MTA1 facilitated endometrial stroma cell proliferation, migration, and invasion by inducing EMT, and the promotion function and MTA1 expression were suppressed by resveratrol, a natural polyphenol. Moreover, we revealed that MTA1 induced EMT through interaction with ZEB2. The findings in a mouse endometriosis model further showed that MTA1 and ZEB2 were upregulated in ectopic tissues and that resveratrol inhibited the growth of ectopic lesions and expression of MTA1 and ZEB2. Taken together, we demonstrate that MTA1 is a protein that promotes EMT via interacting with ZEB2 in the pathogenesis of endometriosis, and may be a target of resveratrol.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (56)
- A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model via openalex
- CAPN 7 promotes the migration and invasion of human endometrial stromal cell by regulating matrix metalloproteinase 2 activity via openalex
- Downregulated circular RNA hsa_circ_0067301 regulates epithelial-mesenchymal transition in endometriosis via the miR-141/Notch signaling pathway via openalex
- Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis still a challenge. via openalex
- Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis via openalex
- Epithelial-to-mesenchymal transition in the development of endometriosis via openalex
- Estradiol promotes EMT in endometriosis via MALAT1/miR200s sponge function via openalex
- E<sub>2</sub>‐mediated EMT by activation of β‐catenin/Snail signalling during the development of ovarian endometriosis via openalex
- Expression of MTA1 in endometriosis and its relationship to the recurrence via openalex
- Long non‐coding RNA AFAP1‐AS1 promoting epithelial‐mesenchymal transition of endometriosis is correlated with transcription factor ZEB1 via openalex
- Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells via openalex
- Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. via openalex
- MicroRNA-126-5p downregulates BCAR3 expression to promote cell migration and invasion in endometriosis via openalex
- microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4 via openalex
- MiR-199a-5p Targets ZEB1 to Inhibit the Epithelial-Mesenchymal Transition of Ovarian Ectopic Endometrial Stromal Cells Via PI3K/Akt/mTOR Signal Pathway In Vitro and In Vivo via openalex
- Natural therapies assessment for the treatment of endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Resveratrol and endometriosis: In vitro and animal studies and underlying mechanisms (Review) via openalex
- Resveratrol Enhances Apoptosis in Endometriotic Stromal Cells via openalex
- Resveratrol reduces the expression of insulin‐like growth factor‐1 and hepatocyte growth factor in stromal cells of women with endometriosis compared with nonendometriotic women via openalex
- Resveratrol successfully treats experimental endometriosis through modulation of oxidative stress and lipid peroxidation via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Role of interleukin-32 in the pathogenesis of endometriosis: in vitro, human and transgenic mouse data via openalex
- The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial via openalex
- Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via openalex
- W2595819742 via openalex
- W1964847767 via openalex
- W1971761901 via openalex
- W1974834178 via openalex
- W1975668484 via openalex
- W1980854517 via openalex
- W2003819108 via openalex
- W2072503088 via openalex
- W2074380974 via openalex
- W2084251750 via openalex
- W2114428497 via openalex
- W2141809016 via openalex
- W2171467827 via openalex
- W2221475995 via openalex
- W2336099036 via openalex
- W2567423087 via openalex
- W2601844293 via openalex
- W2759896015 via openalex
- W2771136768 via openalex
- W2904733559 via openalex
- W2917696579 via openalex
- W2939068656 via openalex
- W2946997059 via openalex
- W2982650366 via openalex
- W2994564894 via openalex
- W6628680024 via openalex
- W6635732373 via openalex
- W6685021758 via openalex
Cited by (14)
- Resveratrol as a protective and ameliorative agent in endometriosis 2026
- Stilbene-based strategies for the management of endometriosis: targeting cell adhesion, migration, and ECM-driven invasion 2026
- Systems Pharmacology Model Predicts Zinc and Copper Can Be Repurposed as Endometriosis Therapies 2025
- Molecular Mechanism of Resveratrol and Its Therapeutic Potential on Female Infertility 2024
- Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis 2023
- Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway 2023
- The effect of two anti-inflammatory dietary components, omega-3 and resveratrol, on endometriosis 2023
- Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review 2022
- O potencial efeito do resveratrol no tratamento da endometriose 2022
- SIRT1 upregulation promotes epithelial-mesenchymal transition by inducing senescence escape in endometriosis 2022
- hsa-miR-340-5p inhibits epithelial–mesenchymal transition in endometriosis by targeting MAP3K2 and inactivating MAPK/ERK signaling 2022
- Phytoestrogens for the Management of Endometriosis: Findings and Issues 2021
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Polyphenols as a Diet Therapy Concept for Endometriosis—Current Opinion and Future Perspectives 2021
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:36.268089+00:00
License: CC0
· commercial use OK